Composition
- Active ingredients
- ROPINIROLE HYDROCHLORIDE EQ 2MG BASE **Federal Register determination that product was not discontinued or withdrawn for safety or effectiveness reasons**
Strengths and forms
The FDA lists each strength of a product separately; these pages share one label.
- ROPINIROLE HYDROCHLORIDE EQ 0.5MG BASE **Federal Register determination that product was not discontinued or withdrawn for safety or effectiveness reasons** · TabletNDA020658-002 · Discontinued
- ROPINIROLE HYDROCHLORIDE EQ 4MG BASE **Federal Register determination that product was not discontinued or withdrawn for safety or effectiveness reasons** · TabletNDA020658-007 · Discontinued
- ROPINIROLE HYDROCHLORIDE EQ 5MG BASE **Federal Register determination that product was not discontinued or withdrawn for safety or effectiveness reasons** · TabletNDA020658-005 · Discontinued
- ROPINIROLE HYDROCHLORIDE EQ 1MG BASE **Federal Register determination that product was not discontinued or withdrawn for safety or effectiveness reasons** · TabletNDA020658-003 · Discontinued
- ROPINIROLE HYDROCHLORIDE EQ 0.25MG BASE **Federal Register determination that product was not discontinued or withdrawn for safety or effectiveness reasons** · TabletNDA020658-001 · Discontinued
- ROPINIROLE HYDROCHLORIDE EQ 3MG BASE **Federal Register determination that product was not discontinued or withdrawn for safety or effectiveness reasons** · TabletNDA020658-006 · Discontinued
- ROPINIROLE HYDROCHLORIDE EQ 2MG BASE **Federal Register determination that product was not discontinued or withdrawn for safety or effectiveness reasons** · TabletThis page
At a glance
- Brand name
- Requip
- Active substance
- ropinirole hydrochloride
- Route
- Oral
- Dosage form
- Tablet
- Applicant
- Glaxosmithkline LLC
- Status
- Discontinued
- FDA approval
- 19 Sept 1997
- Application
- NDA020658-004